The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Live & Inactivated Ruminants Vaccine Market Research Report 2024
Synopsis
Live and inactivated vaccines are both important tools in preventing diseases in ruminant animals such as cattle, sheep, and goats. Live vaccines contain weakened forms of the pathogen, stimulating a strong immune response similar to natural infection without causing disease. These vaccines often provide rapid and long-lasting immunity with fewer doses required but may pose a risk to immunocompromised animals. In contrast, inactivated vaccines contain killed pathogens that cannot cause disease but still trigger an immune response. While generally safer for all animals, they may require multiple doses or boosters for effective immunity. The choice between live and inactivated vaccines depends on factors like disease prevalence, animal health status, and desired duration of immunity, with veterinarians tailoring vaccination programs to optimize herd health and productivity. Regular vaccination plays a critical role in disease prevention and control within ruminant populations.
The global Live & Inactivated Ruminants Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Live & Inactivated Ruminants Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Live & Inactivated Ruminants Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Live & Inactivated Ruminants Vaccine include Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U., Indian Immunologicals Ltd., Vaxxinova International BV (EW Group), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Live & Inactivated Ruminants Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live & Inactivated Ruminants Vaccine.
The Live & Inactivated Ruminants Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Live & Inactivated Ruminants Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live & Inactivated Ruminants Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer Ingelheim International GmbH
Zoetis, Inc.
Merck & Co., Inc.
Bimeda, Inc.
Elanco Animal Health, Inc.
Virbac
Ceva Sante Animale
CZ Vaccines S.A.U.
Indian Immunologicals Ltd.
Vaxxinova International BV (EW Group)
Jinyu Bio-Technology
CNBG
China Animal Husbandry Industry Co., Ltd.
Segment by Type
Modified/ Attenuated Live Vaccines
Inactivated (Killed) Vaccines
Others
Segment by Application
Cattle
Sheep & Goats
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live & Inactivated Ruminants Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live & Inactivated Ruminants Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Live and inactivated vaccines are both important tools in preventing diseases in ruminant animals such as cattle, sheep, and goats. Live vaccines contain weakened forms of the pathogen, stimulating a strong immune response similar to natural infection without causing disease. These vaccines often provide rapid and long-lasting immunity with fewer doses required but may pose a risk to immunocompromised animals. In contrast, inactivated vaccines contain killed pathogens that cannot cause disease but still trigger an immune response. While generally safer for all animals, they may require multiple doses or boosters for effective immunity. The choice between live and inactivated vaccines depends on factors like disease prevalence, animal health status, and desired duration of immunity, with veterinarians tailoring vaccination programs to optimize herd health and productivity. Regular vaccination plays a critical role in disease prevention and control within ruminant populations.
The global Live & Inactivated Ruminants Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Live & Inactivated Ruminants Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Live & Inactivated Ruminants Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Live & Inactivated Ruminants Vaccine include Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U., Indian Immunologicals Ltd., Vaxxinova International BV (EW Group), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Live & Inactivated Ruminants Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live & Inactivated Ruminants Vaccine.
The Live & Inactivated Ruminants Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Live & Inactivated Ruminants Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live & Inactivated Ruminants Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer Ingelheim International GmbH
Zoetis, Inc.
Merck & Co., Inc.
Bimeda, Inc.
Elanco Animal Health, Inc.
Virbac
Ceva Sante Animale
CZ Vaccines S.A.U.
Indian Immunologicals Ltd.
Vaxxinova International BV (EW Group)
Jinyu Bio-Technology
CNBG
China Animal Husbandry Industry Co., Ltd.
Segment by Type
Modified/ Attenuated Live Vaccines
Inactivated (Killed) Vaccines
Others
Segment by Application
Cattle
Sheep & Goats
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live & Inactivated Ruminants Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live & Inactivated Ruminants Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Live & Inactivated Ruminants Vaccine Market Overview
1.1 Product Definition
1.2 Live & Inactivated Ruminants Vaccine by Type
1.2.1 Global Live & Inactivated Ruminants Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Modified/ Attenuated Live Vaccines
1.2.3 Inactivated (Killed) Vaccines
1.2.4 Others
1.3 Live & Inactivated Ruminants Vaccine by Application
1.3.1 Global Live & Inactivated Ruminants Vaccine Market Value by Application (2024-2030)
1.3.2 Cattle
1.3.3 Sheep & Goats
1.4 Global Live & Inactivated Ruminants Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live & Inactivated Ruminants Vaccine Revenue 2019-2030
1.4.2 Global Live & Inactivated Ruminants Vaccine Sales 2019-2030
1.4.3 Global Live & Inactivated Ruminants Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Live & Inactivated Ruminants Vaccine Market Competition by Manufacturers
2.1 Global Live & Inactivated Ruminants Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Live & Inactivated Ruminants Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Live & Inactivated Ruminants Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live & Inactivated Ruminants Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live & Inactivated Ruminants Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live & Inactivated Ruminants Vaccine, Date of Enter into This Industry
2.8 Global Live & Inactivated Ruminants Vaccine Market Competitive Situation and Trends
2.8.1 Global Live & Inactivated Ruminants Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live & Inactivated Ruminants Vaccine Players Market Share by Revenue
2.8.3 Global Live & Inactivated Ruminants Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live & Inactivated Ruminants Vaccine Market Scenario by Region
3.1 Global Live & Inactivated Ruminants Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Live & Inactivated Ruminants Vaccine Sales by Region: 2019-2030
3.2.1 Global Live & Inactivated Ruminants Vaccine Sales by Region: 2019-2024
3.2.2 Global Live & Inactivated Ruminants Vaccine Sales by Region: 2025-2030
3.3 Global Live & Inactivated Ruminants Vaccine Revenue by Region: 2019-2030
3.3.1 Global Live & Inactivated Ruminants Vaccine Revenue by Region: 2019-2024
3.3.2 Global Live & Inactivated Ruminants Vaccine Revenue by Region: 2025-2030
3.4 North America Live & Inactivated Ruminants Vaccine Market Facts & Figures by Country
3.4.1 North America Live & Inactivated Ruminants Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Live & Inactivated Ruminants Vaccine Sales by Country (2019-2030)
3.4.3 North America Live & Inactivated Ruminants Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live & Inactivated Ruminants Vaccine Market Facts & Figures by Country
3.5.1 Europe Live & Inactivated Ruminants Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Live & Inactivated Ruminants Vaccine Sales by Country (2019-2030)
3.5.3 Europe Live & Inactivated Ruminants Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live & Inactivated Ruminants Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live & Inactivated Ruminants Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Live & Inactivated Ruminants Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Live & Inactivated Ruminants Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live & Inactivated Ruminants Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live & Inactivated Ruminants Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Live & Inactivated Ruminants Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Live & Inactivated Ruminants Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Live & Inactivated Ruminants Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live & Inactivated Ruminants Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Live & Inactivated Ruminants Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Live & Inactivated Ruminants Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live & Inactivated Ruminants Vaccine Sales by Type (2019-2030)
4.1.1 Global Live & Inactivated Ruminants Vaccine Sales by Type (2019-2024)
4.1.2 Global Live & Inactivated Ruminants Vaccine Sales by Type (2025-2030)
4.1.3 Global Live & Inactivated Ruminants Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Live & Inactivated Ruminants Vaccine Revenue by Type (2019-2030)
4.2.1 Global Live & Inactivated Ruminants Vaccine Revenue by Type (2019-2024)
4.2.2 Global Live & Inactivated Ruminants Vaccine Revenue by Type (2025-2030)
4.2.3 Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Live & Inactivated Ruminants Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Live & Inactivated Ruminants Vaccine Sales by Application (2019-2030)
5.1.1 Global Live & Inactivated Ruminants Vaccine Sales by Application (2019-2024)
5.1.2 Global Live & Inactivated Ruminants Vaccine Sales by Application (2025-2030)
5.1.3 Global Live & Inactivated Ruminants Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Live & Inactivated Ruminants Vaccine Revenue by Application (2019-2030)
5.2.1 Global Live & Inactivated Ruminants Vaccine Revenue by Application (2019-2024)
5.2.2 Global Live & Inactivated Ruminants Vaccine Revenue by Application (2025-2030)
5.2.3 Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Live & Inactivated Ruminants Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim International GmbH
6.1.1 Boehringer Ingelheim International GmbH Company Information
6.1.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.1.3 Boehringer Ingelheim International GmbH Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim International GmbH Live & Inactivated Ruminants Vaccine Product Portfolio
6.1.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.2 Zoetis, Inc.
6.2.1 Zoetis, Inc. Company Information
6.2.2 Zoetis, Inc. Description and Business Overview
6.2.3 Zoetis, Inc. Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis, Inc. Live & Inactivated Ruminants Vaccine Product Portfolio
6.2.5 Zoetis, Inc. Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Company Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co., Inc. Live & Inactivated Ruminants Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Bimeda, Inc.
6.4.1 Bimeda, Inc. Company Information
6.4.2 Bimeda, Inc. Description and Business Overview
6.4.3 Bimeda, Inc. Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bimeda, Inc. Live & Inactivated Ruminants Vaccine Product Portfolio
6.4.5 Bimeda, Inc. Recent Developments/Updates
6.5 Elanco Animal Health, Inc.
6.5.1 Elanco Animal Health, Inc. Company Information
6.5.2 Elanco Animal Health, Inc. Description and Business Overview
6.5.3 Elanco Animal Health, Inc. Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco Animal Health, Inc. Live & Inactivated Ruminants Vaccine Product Portfolio
6.5.5 Elanco Animal Health, Inc. Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Company Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Virbac Live & Inactivated Ruminants Vaccine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.7.1 Ceva Sante Animale Company Information
6.7.2 Ceva Sante Animale Description and Business Overview
6.7.3 Ceva Sante Animale Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ceva Sante Animale Live & Inactivated Ruminants Vaccine Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 CZ Vaccines S.A.U.
6.8.1 CZ Vaccines S.A.U. Company Information
6.8.2 CZ Vaccines S.A.U. Description and Business Overview
6.8.3 CZ Vaccines S.A.U. Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CZ Vaccines S.A.U. Live & Inactivated Ruminants Vaccine Product Portfolio
6.8.5 CZ Vaccines S.A.U. Recent Developments/Updates
6.9 Indian Immunologicals Ltd.
6.9.1 Indian Immunologicals Ltd. Company Information
6.9.2 Indian Immunologicals Ltd. Description and Business Overview
6.9.3 Indian Immunologicals Ltd. Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Indian Immunologicals Ltd. Live & Inactivated Ruminants Vaccine Product Portfolio
6.9.5 Indian Immunologicals Ltd. Recent Developments/Updates
6.10 Vaxxinova International BV (EW Group)
6.10.1 Vaxxinova International BV (EW Group) Company Information
6.10.2 Vaxxinova International BV (EW Group) Description and Business Overview
6.10.3 Vaxxinova International BV (EW Group) Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vaxxinova International BV (EW Group) Live & Inactivated Ruminants Vaccine Product Portfolio
6.10.5 Vaxxinova International BV (EW Group) Recent Developments/Updates
6.11 Jinyu Bio-Technology
6.11.1 Jinyu Bio-Technology Company Information
6.11.2 Jinyu Bio-Technology Description and Business Overview
6.11.3 Jinyu Bio-Technology Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jinyu Bio-Technology Live & Inactivated Ruminants Vaccine Product Portfolio
6.11.5 Jinyu Bio-Technology Recent Developments/Updates
6.12 CNBG
6.12.1 CNBG Company Information
6.12.2 CNBG Description and Business Overview
6.12.3 CNBG Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CNBG Live & Inactivated Ruminants Vaccine Product Portfolio
6.12.5 CNBG Recent Developments/Updates
6.13 China Animal Husbandry Industry Co., Ltd.
6.13.1 China Animal Husbandry Industry Co., Ltd. Company Information
6.13.2 China Animal Husbandry Industry Co., Ltd. Description and Business Overview
6.13.3 China Animal Husbandry Industry Co., Ltd. Live & Inactivated Ruminants Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 China Animal Husbandry Industry Co., Ltd. Live & Inactivated Ruminants Vaccine Product Portfolio
6.13.5 China Animal Husbandry Industry Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live & Inactivated Ruminants Vaccine Industry Chain Analysis
7.2 Live & Inactivated Ruminants Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live & Inactivated Ruminants Vaccine Production Mode & Process
7.4 Live & Inactivated Ruminants Vaccine Sales and Marketing
7.4.1 Live & Inactivated Ruminants Vaccine Sales Channels
7.4.2 Live & Inactivated Ruminants Vaccine Distributors
7.5 Live & Inactivated Ruminants Vaccine Customers
8 Live & Inactivated Ruminants Vaccine Market Dynamics
8.1 Live & Inactivated Ruminants Vaccine Industry Trends
8.2 Live & Inactivated Ruminants Vaccine Market Drivers
8.3 Live & Inactivated Ruminants Vaccine Market Challenges
8.4 Live & Inactivated Ruminants Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Live & Inactivated Ruminants Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Live & Inactivated Ruminants Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Live & Inactivated Ruminants Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Live & Inactivated Ruminants Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Live & Inactivated Ruminants Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Live & Inactivated Ruminants Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Live & Inactivated Ruminants Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Live & Inactivated Ruminants Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Live & Inactivated Ruminants Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Live & Inactivated Ruminants Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Live & Inactivated Ruminants Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Live & Inactivated Ruminants Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Live & Inactivated Ruminants Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live & Inactivated Ruminants Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Live & Inactivated Ruminants Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Live & Inactivated Ruminants Vaccine Sales by Region (2019-2024) & (K Dose)
Table 18. Global Live & Inactivated Ruminants Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Live & Inactivated Ruminants Vaccine Sales by Region (2025-2030) & (K Dose)
Table 20. Global Live & Inactivated Ruminants Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Live & Inactivated Ruminants Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Live & Inactivated Ruminants Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Live & Inactivated Ruminants Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Live & Inactivated Ruminants Vaccine Sales by Country (2019-2024) & (K Dose)
Table 27. North America Live & Inactivated Ruminants Vaccine Sales by Country (2025-2030) & (K Dose)
Table 28. North America Live & Inactivated Ruminants Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Live & Inactivated Ruminants Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Live & Inactivated Ruminants Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Live & Inactivated Ruminants Vaccine Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Live & Inactivated Ruminants Vaccine Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Live & Inactivated Ruminants Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Live & Inactivated Ruminants Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Live & Inactivated Ruminants Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Live & Inactivated Ruminants Vaccine Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Live & Inactivated Ruminants Vaccine Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Live & Inactivated Ruminants Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Live & Inactivated Ruminants Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Live & Inactivated Ruminants Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Live & Inactivated Ruminants Vaccine Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Live & Inactivated Ruminants Vaccine Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Live & Inactivated Ruminants Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Live & Inactivated Ruminants Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Live & Inactivated Ruminants Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Live & Inactivated Ruminants Vaccine Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Live & Inactivated Ruminants Vaccine Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Live & Inactivated Ruminants Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Live & Inactivated Ruminants Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Live & Inactivated Ruminants Vaccine Sales (K Dose) by Type (2019-2024)
Table 51. Global Live & Inactivated Ruminants Vaccine Sales (K Dose) by Type (2025-2030)
Table 52. Global Live & Inactivated Ruminants Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Live & Inactivated Ruminants Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Live & Inactivated Ruminants Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Live & Inactivated Ruminants Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Live & Inactivated Ruminants Vaccine Price (US$/Dose) by Type (2019-2024)
Table 59. Global Live & Inactivated Ruminants Vaccine Price (US$/Dose) by Type (2025-2030)
Table 60. Global Live & Inactivated Ruminants Vaccine Sales (K Dose) by Application (2019-2024)
Table 61. Global Live & Inactivated Ruminants Vaccine Sales (K Dose) by Application (2025-2030)
Table 62. Global Live & Inactivated Ruminants Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Live & Inactivated Ruminants Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Live & Inactivated Ruminants Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Live & Inactivated Ruminants Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Live & Inactivated Ruminants Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Live & Inactivated Ruminants Vaccine Price (US$/Dose) by Application (2019-2024)
Table 69. Global Live & Inactivated Ruminants Vaccine Price (US$/Dose) by Application (2025-2030)
Table 70. Boehringer Ingelheim International GmbH Company Information
Table 71. Boehringer Ingelheim International GmbH Description and Business Overview
Table 72. Boehringer Ingelheim International GmbH Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim International GmbH Live & Inactivated Ruminants Vaccine Product
Table 74. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 75. Zoetis, Inc. Company Information
Table 76. Zoetis, Inc. Description and Business Overview
Table 77. Zoetis, Inc. Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Zoetis, Inc. Live & Inactivated Ruminants Vaccine Product
Table 79. Zoetis, Inc. Recent Developments/Updates
Table 80. Merck & Co., Inc. Company Information
Table 81. Merck & Co., Inc. Description and Business Overview
Table 82. Merck & Co., Inc. Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Merck & Co., Inc. Live & Inactivated Ruminants Vaccine Product
Table 84. Merck & Co., Inc. Recent Developments/Updates
Table 85. Bimeda, Inc. Company Information
Table 86. Bimeda, Inc. Description and Business Overview
Table 87. Bimeda, Inc. Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Bimeda, Inc. Live & Inactivated Ruminants Vaccine Product
Table 89. Bimeda, Inc. Recent Developments/Updates
Table 90. Elanco Animal Health, Inc. Company Information
Table 91. Elanco Animal Health, Inc. Description and Business Overview
Table 92. Elanco Animal Health, Inc. Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Elanco Animal Health, Inc. Live & Inactivated Ruminants Vaccine Product
Table 94. Elanco Animal Health, Inc. Recent Developments/Updates
Table 95. Virbac Company Information
Table 96. Virbac Description and Business Overview
Table 97. Virbac Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Virbac Live & Inactivated Ruminants Vaccine Product
Table 99. Virbac Recent Developments/Updates
Table 100. Ceva Sante Animale Company Information
Table 101. Ceva Sante Animale Description and Business Overview
Table 102. Ceva Sante Animale Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Ceva Sante Animale Live & Inactivated Ruminants Vaccine Product
Table 104. Ceva Sante Animale Recent Developments/Updates
Table 105. CZ Vaccines S.A.U. Company Information
Table 106. CZ Vaccines S.A.U. Description and Business Overview
Table 107. CZ Vaccines S.A.U. Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. CZ Vaccines S.A.U. Live & Inactivated Ruminants Vaccine Product
Table 109. CZ Vaccines S.A.U. Recent Developments/Updates
Table 110. Indian Immunologicals Ltd. Company Information
Table 111. Indian Immunologicals Ltd. Description and Business Overview
Table 112. Indian Immunologicals Ltd. Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Indian Immunologicals Ltd. Live & Inactivated Ruminants Vaccine Product
Table 114. Indian Immunologicals Ltd. Recent Developments/Updates
Table 115. Vaxxinova International BV (EW Group) Company Information
Table 116. Vaxxinova International BV (EW Group) Description and Business Overview
Table 117. Vaxxinova International BV (EW Group) Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Vaxxinova International BV (EW Group) Live & Inactivated Ruminants Vaccine Product
Table 119. Vaxxinova International BV (EW Group) Recent Developments/Updates
Table 120. Jinyu Bio-Technology Company Information
Table 121. Jinyu Bio-Technology Description and Business Overview
Table 122. Jinyu Bio-Technology Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Jinyu Bio-Technology Live & Inactivated Ruminants Vaccine Product
Table 124. Jinyu Bio-Technology Recent Developments/Updates
Table 125. CNBG Company Information
Table 126. CNBG Description and Business Overview
Table 127. CNBG Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. CNBG Live & Inactivated Ruminants Vaccine Product
Table 129. CNBG Recent Developments/Updates
Table 130. China Animal Husbandry Industry Co., Ltd. Company Information
Table 131. China Animal Husbandry Industry Co., Ltd. Description and Business Overview
Table 132. China Animal Husbandry Industry Co., Ltd. Live & Inactivated Ruminants Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 133. China Animal Husbandry Industry Co., Ltd. Live & Inactivated Ruminants Vaccine Product
Table 134. China Animal Husbandry Industry Co., Ltd. Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Live & Inactivated Ruminants Vaccine Distributors List
Table 138. Live & Inactivated Ruminants Vaccine Customers List
Table 139. Live & Inactivated Ruminants Vaccine Market Trends
Table 140. Live & Inactivated Ruminants Vaccine Market Drivers
Table 141. Live & Inactivated Ruminants Vaccine Market Challenges
Table 142. Live & Inactivated Ruminants Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Live & Inactivated Ruminants Vaccine
Figure 2. Global Live & Inactivated Ruminants Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Live & Inactivated Ruminants Vaccine Market Share by Type: 2023 & 2030
Figure 4. Modified/ Attenuated Live Vaccines Product Picture
Figure 5. Inactivated (Killed) Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Live & Inactivated Ruminants Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Live & Inactivated Ruminants Vaccine Market Share by Application: 2023 & 2030
Figure 9. Cattle
Figure 10. Sheep & Goats
Figure 11. Global Live & Inactivated Ruminants Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Live & Inactivated Ruminants Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Live & Inactivated Ruminants Vaccine Sales (2019-2030) & (K Dose)
Figure 14. Global Live & Inactivated Ruminants Vaccine Average Price (US$/Dose) & (2019-2030)
Figure 15. Live & Inactivated Ruminants Vaccine Report Years Considered
Figure 16. Live & Inactivated Ruminants Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Live & Inactivated Ruminants Vaccine Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Live & Inactivated Ruminants Vaccine Players: Market Share by Revenue in Live & Inactivated Ruminants Vaccine in 2023
Figure 19. Live & Inactivated Ruminants Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Live & Inactivated Ruminants Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Live & Inactivated Ruminants Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Live & Inactivated Ruminants Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Live & Inactivated Ruminants Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Live & Inactivated Ruminants Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Live & Inactivated Ruminants Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Live & Inactivated Ruminants Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Live & Inactivated Ruminants Vaccine Sales Market Share by Country (2019-2030)
Figure 42. Mexico Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Live & Inactivated Ruminants Vaccine Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Live & Inactivated Ruminants Vaccine Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Live & Inactivated Ruminants Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Live & Inactivated Ruminants Vaccine by Type (2019-2030)
Figure 52. Global Revenue Market Share of Live & Inactivated Ruminants Vaccine by Type (2019-2030)
Figure 53. Global Live & Inactivated Ruminants Vaccine Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of Live & Inactivated Ruminants Vaccine by Application (2019-2030)
Figure 55. Global Revenue Market Share of Live & Inactivated Ruminants Vaccine by Application (2019-2030)
Figure 56. Global Live & Inactivated Ruminants Vaccine Price (US$/Dose) by Application (2019-2030)
Figure 57. Live & Inactivated Ruminants Vaccine Value Chain
Figure 58. Live & Inactivated Ruminants Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
